GlassScriptPhysician profile
John M Taylor
NPI 1457322554
$18,475.22
in general payments reported to CMS, 2019-2025
15 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,110 · 2020: $1,910 · 2021: $2,626 · 2022: $2,999 · 2023: $2,134 · 2024: $1,511 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,829.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $10,222.21 | 2019-2024 | Xeomin |
| Allergan, INC. | $3,344.09 | 2019-2022 | |
| Abbvie INC. | $1,366.92 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Revance Therapeutics, INC. | $947.68 | 2024-2025 | Daxxify |
| Sientra, INC. | $633.47 | 2022 | |
| Tela Bio, INC. | $581.71 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $439.36 | 2019-2022 | |
| Convatec INC. | $219.78 | 2024 | |
| Polynovo North America LLC | $171.85 | 2023 | |
| Motiva USA, LLC | $169.63 | 2025 | |
| Acera Surgical, INC. | $160.85 | 2024 | Restrata Wound Matrix |
| Baudax Bio INC. | $124.77 | 2022 | |
| Mentor Worldwide LLC | $47.36 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $30.70 | 2019-2024 | Exparel, Iovera, Zilretta |
| Galderma Laboratories, L.P. | $14.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.